Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Pharmaceutics|August 28, 2021
The Potential to Reduce Patient Co-Payment and the Public Payer Spending in Poland through an Optimised Implementation of the Generic Substitution: The Win-Win Scenario Suggested by the Real-World Big Data AnalysisPrzemysław Kardas, Aneta Lichwierowicz, Filip Urbański, et al.
Frontiers in Psychiatry|January 22, 2026
Depressive and anxiety disorders in Polish children across the COVID-19 pandemic: a nationwide registry-based time-trend analysisMarcin Czech, Malwina Hołownia-Voloskova, Katarzyna Bliźniewska-Kowalska, et al.
World Journal of Surgery|January 13, 2016
In-Hospital Mortality in a 4-Year Cohort Study of 3,093,254 Operations in SeniorsMonika Puzianowska-Kuznicka, Magdalena Walicka, Boguslawa Osinska, et al.
Frontiers in Pharmacology|January 23, 2026
Medication use in Poland for children and adolescents with neurodevelopmental disorders: before, during and after the COVID-19 pandemic - a retrospective pharmacoepidemiological study using national reimbursement dataAndrzej Silczuk, Malwina Hołownia-Voloskova, Anna Mosiołek, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 5, 2016
Patient's age rather than severity of the arrhythmia influences the cost of medical treatment of atrioventricular nodal or atrioventricular reciprocating tachycardiaMichal M Farkowski, Mariusz Pytkowski, Aleksander Maciag, et al.
Journal of Market Access & Health Policy|June 26, 2025
Optimizing Patient Access to Orphan Medicinal Products: Lessons from Central and Eastern EuropeTomasz Kluszczynski, Bertalan Nemeth, Magdalena Władysiuk, et al.
Archives of Medical Science : AMS|December 13, 2021
Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland - real-world dataMelania Brzozowska, Waldemar Wierzba, Sylwia Szafraniec-Buryło, et al.
Kardiologia Polska|April 12, 2013
The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARDMarcin Czech, Grzegorz Opolski, Tomasz Zdrojewski, et al.
Journal of Diabetes|April 26, 2024
Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model-A multiregional case studyHussain Abdulrahman Al-Omar, Marcin Czech, Tran Quang Nam, et al.
Viruses|May 25, 2024
Epidemiology of Respiratory Syncytial Virus Hospitalizations in Poland: An Analysis from 2015 to 2023 Covering the Entire Polish Population of Children Aged under Five YearsJan Mazela, Teresa Jackowska, Marcin Czech, et al.
Pageof 7